121 related articles for article (PubMed ID: 11571010)
1. Cost-effectiveness of prevention referrals for high-risk HIV-negatives in San Francisco.
Heumann KS; Marx R; Lawrence SJ; Stump DL; Carroll DP; Hirozawa AM; Katz MH; Kahn JG
AIDS Care; 2001 Oct; 13(5):637-42. PubMed ID: 11571010
[TBL] [Abstract][Full Text] [Related]
2. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
3. HIV prevention case management in San Francisco: barriers to successful implementation.
Sebesta DS; Marx R; Liu Y
AIDS Care; 2006 May; 18(4):345-55. PubMed ID: 16809112
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
5. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.
Wilson AR; Kahn JG
J Urban Health; 2003 Sep; 80(3):465-81. PubMed ID: 12930884
[TBL] [Abstract][Full Text] [Related]
6. Linking clients from HIV antibody counseling and testing to prevention services.
Marx R; Hirozawa AM; Chu PL; Bolan GA; Katz MH
J Community Health; 1999 Jun; 24(3):201-14. PubMed ID: 10399652
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
[TBL] [Abstract][Full Text] [Related]
8. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
Sante; 1999; 9(5):277-81. PubMed ID: 10657769
[TBL] [Abstract][Full Text] [Related]
9. Costs and effectiveness of finding new HIV diagnoses by using rapid testing in transgender communities.
Shrestha RK; Sansom SL; Schulden JD; Song B; Smith LC; Ramirez R; Mares-DelGrasso A; Heffelfinger JD
AIDS Educ Prev; 2011 Jun; 23(3 Suppl):49-57. PubMed ID: 21689036
[TBL] [Abstract][Full Text] [Related]
10. HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour.
Scheer S; Kellogg T; Klausner JD; Schwarcz S; Colfax G; Bernstein K; Louie B; Dilley JW; Hecht J; Truong HM; Katz MH; McFarland W
Sex Transm Infect; 2008 Nov; 84(6):493-8. PubMed ID: 19028954
[TBL] [Abstract][Full Text] [Related]
11. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting?
Truong HM; Kellogg T; Klausner JD; Katz MH; Dilley J; Knapper K; Chen S; Prabhu R; Grant RM; Louie B; McFarland W
Sex Transm Infect; 2006 Dec; 82(6):461-6. PubMed ID: 17151031
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
Pinkerton SD; Holtgrave DR; Bloom FR
AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
[TBL] [Abstract][Full Text] [Related]
13. HIV prevention programs proven cost-effective.
AIDS Alert; 1998 Sep; 13(9):107-8. PubMed ID: 11365792
[TBL] [Abstract][Full Text] [Related]
14. HIV risk behavior, street outreach, and condom use in eight high-risk populations.
Anderson JE; Cheney R; Clatts M; Faruque S; Kipke M; Long A; Mills S; Toomey K; Wiebel W
AIDS Educ Prev; 1996 Jun; 8(3):191-204. PubMed ID: 8806949
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
[TBL] [Abstract][Full Text] [Related]
16. San Francisco serosorting may explain odd HIV data. STDs have risen, but not new HIV infections.
AIDS Alert; 2004 May; 19(5):55-6. PubMed ID: 15206356
[TBL] [Abstract][Full Text] [Related]
17. Estimation of HIV incidence in San Francisco.
Scheer S; Chin CS; Buckman A; McFarland W
AIDS; 2009 Feb; 23(4):533-4. PubMed ID: 19155994
[TBL] [Abstract][Full Text] [Related]
18. HIV prevention case management is not cost-effective.
Cohen DA; Wu SY; Farley TA
Am J Public Health; 2006 Mar; 96(3):400-1; author reply 401. PubMed ID: 16449573
[No Abstract] [Full Text] [Related]
19. Social marketing and diffusion-based strategies for communicating with unique populations: HIV prevention in San Francisco.
Dearing JW; Rogers EM; Meyer G; Casey MK; Rao N; Campo S; Henderson GM
J Health Commun; 1996; 1(4):343-63. PubMed ID: 10947368
[TBL] [Abstract][Full Text] [Related]
20. "I have it just like you do": voices of HIV-negative partners in serodifferent relationships receiving primary care at a public clinic in San Francisco.
Mahoney M; Weber S; Bien M; Saba G
AIDS Care; 2015; 27(3):401-8. PubMed ID: 25311152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
